With such limitations, a simple and cost-effective PCR based test for SHANK3 deletion can be an effective tool for screening–especially for patients showing Phelan-McDermid syndrome (depending on examination results from neuropsychiatrist). The gene discussed is SHANK3; the disease is Monosomy 22q13.